Arabella
Analyst
H.C. Wainwright
Equibles does not estimate personal net worth.
About Arabella
Arabella is recorded as Analyst at H.C. Wainwright. Arabella has spoken on 2 earnings calls across 2 companies, most recently for Vir Biotechnology, Inc. on August 5, 2026. Those appearances were for Vir Biotechnology, Inc. (VIR) and Definium Therapeutics, Inc. (DFTX). The companies whose calls Arabella spoke on are classified in the Healthcare sector.
Arabella on recent calls
“I guess given the field in HDV kind of shift towards focusing on TND more, I was wondering if the FDA has shared their view on TND alone versus TND plus alt-normalization.”
“We're looking forward to the upcoming readout. Since Panorama also includes European sites, are there any meaningful differences in diagnostic practice, placebo behavior, or standard of care that could introduce additional variability?”
Affiliation history
-
H.C. Wainwright
Analyst
Transcript header (unverified)
Current